Patent ID: 7381826

Claim:
A crystalline Form IV {2-[1-(3,5-bistrifluoromethylbenzyl)-5-pyridin-4-yl-1H-[1,2,3 ]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone characterized by at least one of the following: a) a solid-state 13 C nuclear magnetic resonance spectrum comprising peaks at the following chemical shifis: 52.3±0.2 and 195.4±0.2 ppm; b) an X-ray powder diffraction pattern comprising at least two peaks wherein one peak is 12.1±0.1°, and the second peak is selected from the group consisting of 8.3=0.1°, 14.3±0.1°, 16.6±0.1°, 16.9±0.1°, and 18.5±0.1in 2θ; and c) an X-ray powder diffraction pattern comprising at least the following peaks: 8.3±0.1°, 12.1±0.1°, 16.6±0.1°, 16.9±0.1°, and 18.5±0.1° in 2θ.